Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ChitoSkin is a chitosan-based medical device and wound dressing developed for the management of various skin injuries, including chronic ulcers, surgical wounds, and burns. Composed of high-purity chitosan—a natural biopolymer derived from crustacean chitin—ChitoSkin functions by creating a biocompatible, biodegradable scaffold that supports cellular infiltration and tissue regeneration. Its primary mechanism of action involves the polycationic nature of the chitosan molecules, which interact electrostatically with the negatively charged membranes of red blood cells and platelets to promote rapid hemostasis. Furthermore, ChitoSkin exhibits intrinsic antimicrobial properties by disrupting bacterial cell membranes and provides a moist environment that facilitates the migration of fibroblasts and keratinocytes, thereby accelerating the wound-healing process.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ChitoSkin.